Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Research
    • Safety
    • COVID-19
    • Drug Reference Sheet
    • Special Populations
    • ONS Congress Newscast
    View All Topics
    Advocacy
    • Latest Articles
    • Get Involved
    Stories View All
    View All
    ONS Members Tell Us About the Inspirational Nurses Who’ve Shaped Their Careers
    Nurse well-being
    ONS Members Tell Us About the Inspirational Nurses Who’ve Shaped Their Careers
    November 23, 2023
    Nurse Educator–Led Educational Fairs Help Reduce Hospital-Acquired Conditions
    Oncology nurse education
    Nurse Educator–Led Educational Fairs Help Reduce Hospital-Acquired Conditions
    November 10, 2023
    When the Nurse Coach Becomes the Client: How I Restored Balance and Set Goals on a Healing Journey
    Oncology nurse influence
    When the Nurse Coach Becomes the Client: How I Restored Balance and Set Goals on a Healing Journey
    November 03, 2023
    Filipino American History Month nurse standing next to flag
    Nurse empowerment
    Filipino American History Month Shines Light on the Contributions and Challenges of a Committed Community of Nurses
    October 16, 2023
    Explore Somatic Biomarker Testing Report Component Biomarker Testing
    Clinical practice
    Learn How to Read a Somatic Biomarker Testing Report
    October 06, 2023
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    Manage Thrombosis in Patients With Cancer
    Symptom management

    Manage Thrombosis in Patients With Cancer

    Thrombotic events are the second-leading cause of death in patients with cancer after the disease itself. An estimated 4%–20% of patients experience venous thromboembolism at some stage on the cancer journey. 

    April 09, 2020
    BRAF Mutations Guide Treatment in Metastatic Colorectal Cancer
    Clinical practice

    BRAF Mutations Guide Treatment in Metastatic Colorectal Cancer

    Molecular profiling has become essential for the treatment of metastatic colorectal cancer (CRC) when surgery cannot be considered and systemic therapy is recommended. CRC has several potential mutations that are diagnostic, prognostic, and predictive. National Comprehensive Cancer Network (NCCN) guidelines recommend that advanced practice providers conduct RAS, BRAF, HER2, and MSI testing as part of a full molecular panel, review the results, and acted on them prior to starting patients on systemic therapy.

    February 24, 2020
    Newer Therapies at Last Offer Systemic Options for Metastatic HCC
    Advanced Practice Nursing (APRN)

    Newer Therapies at Last Offer Systemic Options for Metastatic HCC

    Already the third leading cause of cancer deaths worldwide, hepatocellular carcinoma (HCC) is a continually growing burden as the incidence of obesity, type II diabetes, and hypertension also increase, which may lead to cirrhosis and nonalcoholic fatty liver disease. Its incidence is highest in Asia and Africa, where the prevalence of hepatitis B and hepatitis C may result in chronic liver disease and subsequently HCC. 

    December 12, 2019
    To Prevent Hepatoxicity, Monitor Liver Function During Cancer Treatment
    Advanced Practice Nursing (APRN)

    To Prevent Hepatotoxicity, Monitor Liver Function During Cancer Treatment

    Because the liver is the primary site of metabolism for many drugs, baseline function testing and monitoring during cancer treatment are essential. However, the cause of an abnormal liver function test when a patient is receiving chemotherapy or immunotherapy can be difficult to determine. 

    August 28, 2019
    Stay Up to Date on Clinical Treatments for Metastatic CRC
    Advanced Practice Nursing (APRN)

    Stay Up to Date on Clinical Treatments for Metastatic CRC

    Metastatic colorectal cancer (CRC) remains a significant health problem as the second leading cause of cancer death in the United States and the fourth most frequently diagnosed cancer. Despite improvements in some age groups, its incidence has actually been increasing in patients younger than 50 years. The cause of this trend is currently unknown.   

    May 02, 2019
    What Is the APRN’s Role in Managing Patients Receiving Targeted Therapy?
    Targeted therapy

    What Is the APRN’s Role in Managing Patients Receiving Targeted Therapy?

    Targeted therapies block the growth of cancer by interfering with specific molecules and may also be referred to as molecularly targeted drugs or precision oncology. Advanced practice RNs (APRNs) must be familiar with the various agents and their side effect profiles, including immunotherapies, hormone therapies, apoptosis inducers, monoclonal antibodies, angiogenesis inhibitors, and signal transduction inhibitors. 

    March 07, 2019
    The Role of the APRN in Monitoring Patients Receiving Peptide Receptor Radionuclide Therapy
    Advanced Practice Nursing (APRN)

    The Role of the APRN in Monitoring Patients Receiving Peptide Receptor Radionuclide Therapy

    Neuroendocrine cancers are rare malignancies; however, their incidence is thought to be increasing. Such tumors are characterized by their overexpression of somatostatin receptors, present in up to 80% of cases. However, a novel radiopharmaceutical may give advanced practice RNs (APRNs) a new option to treat certain gastroenteropancreatic neuroendocrine tumors.

    January 17, 2019
    Comprehensive
    Survivorship

    APRN-Led Clinics Enable Comprehensive Survivorship Care

    A survivorship clinic allows APRNs to practice autonomously and highlights their strengths and skills, including assessing long-term toxicities, providing expert symptom management, coordinating with other disciplines, and making referrals as appropriate. Long-term toxicities from cancer treatment are disease- and treatment-specific and will be unique to each patient.

    November 27, 2018

    To discuss the information in this article with other oncology nurses, visit the ONS Communities.

    To report a content error, inaccuracy, or typo, email pubONSVoice@ons.org.

    Nicole Ross CRNP, MSN, AOCNP®
     
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2023 Oncology Nursing Society
     
    Back to Top ▲